Efficacy and Safety of Combined Vitrectomy with Intravitreal Dexamethasone Implant for Advanced Stage Epiretinal Membrane

References

• Ng CH, Cheung N, Wang JJ, et al. Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population. Ophthalmology. 2011;118(4):694–699. doi:10.1016/j.ophtha.2010.08.00921035863
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes: the blue mountains eye study, Australia. Ophthalmology. 1997;104(6):1033–1040. doi:10.1016/S0161-6420(97)30190-09186446
   PubMed Web of Science ®Google Scholar
• Smiddy WE, Michels RG, Green WR. Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina. 1990;10(4):288–296. doi:10.1097/00006982-199010000-00012.2089546
   PubMed Web of Science ®Google Scholar
• Miliatos I, Lindgren G. Epiretinal membrane surgery evaluated by subjective outcome. Acta Ophthalmol. 2017;95(1):52–59. doi:10.1111/aos.1300127041544
   PubMed Web of Science ®Google Scholar
• Kim SJ, Martin DF, Hubbard GB, et al. Incidence of postvitrectomy macular edema using optical coherence tomography. Ophthalmology. 2009;116(8):1531–1537. doi:10.1016/j.ophtha.2009.02.00819501405
   PubMed Web of Science ®Google Scholar
• Frisina R, Pinackatt SJ, Sartore M, et al. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefe’s Arch Clin Exp Ophthalmol. 2014;253(1):47–56. doi:10.1007/s00417-014-2655-x24859385
   PubMed Web of Science ®Google Scholar
• Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol. 2009;147(1):11–21.e1. doi:10.1016/j.ajo.2008.07.02418789796
   PubMed Web of Science ®Google Scholar
• Hattenbach LO, Springer-Wanner C, Hoerauf H, et al. Intravitreal sustained-release steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes. Ophthalmologica. 2017;237(4):232–237. doi:10.1159/00046425928463851
   PubMed Web of Science ®Google Scholar
• Furino C, Boscia F, Recchimurzo N, Sborgia C, Alessio G. Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker. Retina. 2014;34(8):1612–1616. doi:10.1097/IAE.000000000000010524752008
   PubMed Web of Science ®Google Scholar
• Suzuki T, Hayakawa K, Nakagawa Y, Onouchi H, Ogata M, Kawai K. Topical dorzolamide for macular edema in the early phase after vitrectomy and epiretinal membrane removal. Clin Ophthalmol. 2013;7:549–553. doi:10.2147/OPTH.S4218823620653
   PubMedGoogle Scholar
• Govetto A, Lalane RA, Sarraf D, Figueroa MS, Hubschman JP. Insights into epiretinal membranes: presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme. Am J Ophthalmol. 2017;175:99–113. doi:10.1016/j.ajo.2016.12.00627993592
   PubMed Web of Science ®Google Scholar
• Chatziralli I, Dimitriou E, Theodossiadis G, Chatzirallis A, Kazantzis D, Theodossiadis P. Treatment of macular edema after pars plana vitrectomy for idiopathic epiretinal membrane using intravitreal dexamethasone implant: long-term outcomes. Ophthalmologica. 2019;1–6. doi:10.1159/000496705
   Web of Science ®Google Scholar
• Compera D, Entchev E, Haritoglou C, et al. Lamellar hole–associated epiretinal proliferation in comparison to epiretinal membranes of macular pseudoholes. Am J Ophthalmol. 2015;160(2):373–384.e1. doi:10.1016/j.ajo.2015.05.01025982970
   PubMed Web of Science ®Google Scholar
• Azzolini C, Congiu T, Donati S, et al. Multilayer microstructure of idiopathic epiretinal macular membranes. Eur J Ophthalmol. 2017;27(6):762–768. doi:10.5301/ejo.500098228525683
   PubMed Web of Science ®Google Scholar
• Tso MO. Pathology of cystoid macular edema. Ophthalmology. 1982;89(8):902–915. doi:10.1016/S0161-6420(82)34698-9.7133637
   PubMed Web of Science ®Google Scholar
• Yonekawa Y, Mammo DA, Thomas BJ, Wolfe JD, Hassan TS. A comparison of intraoperative dexamethasone intravitreal implant and triamcinolone acetonide used during vitrectomy and epiretinal membrane peeling: a case control study. Ophthalmic Surgery, Lasers Imaging Retin. 2016;47(3):232–237. doi:10.3928/23258160-20160229-05
   PubMed Web of Science ®Google Scholar
• Guidi G, Casini G, Ripandelli G, et al. Residual intraretinal edema after 25-gauge vitrectomy and macular pucker removal: is intraoperative sustained-release dexamethasone a real treatment option? Retina. 2017:993–999. doi:10.1097/IAE.0000000000001627.
   Web of Science ®Google Scholar
• Song SJ, Lee MY, Smiddy WE. Ganglion cell layer thickness and visual improvement after epiretinal membrane surgery. Retina. 2016;36(2):305–310. doi:10.1097/IAE.000000000000070526296145
   PubMed Web of Science ®Google Scholar
• Boyer DS, Faber D, Gupta S, et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011;31(5):915–923. doi:10.1097/IAE.0b013e318206d18c21487341
   PubMed Web of Science ®Google Scholar
• Dutra Medeiros M, Alkabes M, Navarro R, Garcia-Arumí J, Mateo C, Corcóstegui B. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema. J Ocul Pharmacol Ther. 2014;30(9):709–716. doi:10.1089/jop.2014.001025259834
   PubMed Web of Science ®Google Scholar
• Rajesh B, Zarranz-Ventura J, Fung AT, et al. Safety of 6000 intravitreal dexamethasone implants. Br J Ophthalmol. 2019: bjophthalmol-2019-313991. doi:10.1136/bjophthalmol-2019-313991.
   PubMed Web of Science ®Google Scholar
• Azuma K, Ueta T, Eguchi S, Aihara M. Effects of internal limiting membrane peeling combined with removal of idiopathic epiretinal membrane a systematic review of literature and meta-analysis. Retina. 2017:1–7. doi:10.1097/IAE.0000000000001537
   Web of Science ®Google Scholar
• Chin HS, Park TS, Moon YS, Oh JH. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina. 2005;25(5):556–560. doi:10.1097/00006982-200507000-0000216077349
   PubMed Web of Science ®Google Scholar